- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 114-128 of
276 results
1020 Exhibit: Exhibit 1020 Nilsson, SF et al, ¿¿¿Increased uveoscleral outflow as a p...
Document
IPR2017-01434, No. 1020-20 Exhibit - Exhibit 1020 Nilsson, SF et al, ¿¿¿Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha 1 isopro...
|
|
Cite Document
1057 Exhibit: Exhibit 1057 Aerie Pharmaceuticals, Inc Form 8 K 2017
Document
IPR2017-01434, No. 1057-105 Exhibit - Exhibit 1057 Aerie Pharmaceuticals, Inc Form 8 K 2017 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
2039 Exhibit: Ex2039 Lumigan 001 Label
Document
IPR2017-01434, No. 2039-69 Exhibit - Ex2039 Lumigan 001 Label (P.T.A.B. Mar. 5, 2018)
|
|
Cite Document
1053 Exhibit: Santen Pharmaceutical Co, Ltd Annual Report 2013
Document
IPR2017-01434, No. 1053-101 Exhibit - Santen Pharmaceutical Co, Ltd Annual Report 2013 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
2017 Exhibit: Ex 2017 EP0364417A1
Document
IPR2017-01434, No. 2017-45 Exhibit - Ex 2017 EP0364417A1 (P.T.A.B. Sep. 7, 2017)
|
|
Cite Document
1031 Exhibit: Supplemental Declaration of Mitchell A deLong, PhD
Document
IPR2017-01434, No. 1031-79 Exhibit - Supplemental Declaration of Mitchell A deLong, PhD (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
1060 Exhibit: Exhibit 1060 Santen Pharmaceutical Co, Ltd Annual Report 2014
Document
IPR2017-01434, No. 1060-108 Exhibit - Exhibit 1060 Santen Pharmaceutical Co, Ltd Annual Report 2014 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
2034 Exhibit: Ex2034 Wang 1998
Document
IPR2017-01434, No. 2034-64 Exhibit - Ex2034 Wang 1998 (P.T.A.B. Mar. 5, 2018)
|
|
Cite Document
2045 Exhibit: Ex2045 Micro Labs Complaint
Document
IPR2017-01434, No. 2045-75 Exhibit - Ex2045 Micro Labs Complaint (P.T.A.B. Mar. 5, 2018)
|
|
Cite Document
2006 Exhibit: Ex 2006 Linden 1999
Document
IPR2017-01434, No. 2006-34 Exhibit - Ex 2006 Linden 1999 (P.T.A.B. Sep. 7, 2017)
|
|
Cite Document
1019 Exhibit: Exhibit 1019 Camras, CB et al, ¿¿¿Maintained reduction of intraocular p...
Document
IPR2017-01434, No. 1019-19 Exhibit - Exhibit 1019 Camras, CB et al, ¿¿¿Maintained reduction of intraocular pressure by prostaglandin F2 alpha 1 isopropyl ester applied in multiple doses in ocu...
|
|
Cite Document
1015 Exhibit: Exhibit 1015 Stjernschantz J 1992 Drugs of the Future
Document
IPR2017-01434, No. 1015-15 Exhibit - Exhibit 1015 Stjernschantz J 1992 Drugs of the Future (P.T.A.B. May. 12, 2017)
|
|
Cite Document
1058 Exhibit: Santen Pharmaceutical Co, Ltd Data Book 2015
Document
IPR2017-01434, No. 1058-106 Exhibit - Santen Pharmaceutical Co, Ltd Data Book 2015 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
1048 Exhibit: Skuballa W et al, ¿¿¿15, 15 Ketals of NaturalProstaglandins and Prosta...
Document
IPR2017-01434, No. 1048-96 Exhibit - Skuballa W et al, ¿¿¿15, 15 Ketals of NaturalProstaglandins and Prostaglandin Analogues Synthesis and Biological Activities,¿¿¿ J Med Chem 21443¿¿¿447 19...
|
|
Cite Document
2048 Exhibit: Ex2048 Carey 1984
Document
IPR2017-01434, No. 2048-78 Exhibit - Ex2048 Carey 1984 (P.T.A.B. Mar. 5, 2018)
|
|
Cite Document
